[HTML][HTML] Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease …
JF Donohue, D Niewoehner, J Brooks, D O'Dell… - Respiratory …, 2014 - Springer
Background The long-acting muscarinic antagonist (LAMA) umeclidinium (UMEC) and the
combination of UMEC with the long-acting β 2-agonist (LABA) vilanterol (UMEC/VI) are …
combination of UMEC with the long-acting β 2-agonist (LABA) vilanterol (UMEC/VI) are …
Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results …
JF Donohue, D Niewoehner, J Brooks, D O'Dell… - Respiratory …, 2014 - go.gale.com
Background Chronic obstructive pulmonary disease (COPD) is a preventable and treatable
condition characterized by persistent airflow obstruction that is not fully reversible [1]. The …
condition characterized by persistent airflow obstruction that is not fully reversible [1]. The …
Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results …
JF Donohue, D Niewoehner, J Brooks… - Respiratory …, 2014 - search.ebscohost.com
Background: The long-acting muscarinic antagonist (LAMA) umeclidinium (UMEC) and the
combination of UMEC with the long-acting β2-agonist (LABA) vilanterol (UMEC/VI) are …
combination of UMEC with the long-acting β2-agonist (LABA) vilanterol (UMEC/VI) are …
Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results …
JF Donohue, D Niewoehner, J Brooks, D O'Dell… - Respiratory …, 2014 - infona.pl
Background The long-acting muscarinic antagonist (LAMA) umeclidinium (UMEC) and the
combination of UMEC with the long-acting β2-agonist (LABA) vilanterol (UMEC/VI) are …
combination of UMEC with the long-acting β2-agonist (LABA) vilanterol (UMEC/VI) are …
Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results …
JF Donohue, D Niewoehner, J Brooks… - Respiratory …, 2014 - pubmed.ncbi.nlm.nih.gov
Background The long-acting muscarinic antagonist (LAMA) umeclidinium (UMEC) and the
combination of UMEC with the long-acting β2-agonist (LABA) vilanterol (UMEC/VI) are …
combination of UMEC with the long-acting β2-agonist (LABA) vilanterol (UMEC/VI) are …
Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results …
JF Donohue, D Niewoehner, J Brooks, D O'Dell… - Respiratory …, 2014 - hero.epa.gov
Background: The long-acting muscarinic antagonist (LAMA) umeclidinium (UMEC) and the
combination of UMEC with the long-acting beta (2)-agonist (LABA) vilanterol (UMEC/VI) are …
combination of UMEC with the long-acting beta (2)-agonist (LABA) vilanterol (UMEC/VI) are …
[引用][C] Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease …
JF Donohue, D Niewoehner, J Brooks, D O'Dell… - Respiratory …, 2014 - cir.nii.ac.jp
Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125
mcg in patients with chronic obstructive pulmonary disease: results from a 52-week …
mcg in patients with chronic obstructive pulmonary disease: results from a 52-week …
Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results …
JF Donohue, D Niewoehner, J Brooks… - Respiratory …, 2014 - europepmc.org
Background The long-acting muscarinic antagonist (LAMA) umeclidinium (UMEC) and the
combination of UMEC with the long-acting β2-agonist (LABA) vilanterol (UMEC/VI) are …
combination of UMEC with the long-acting β2-agonist (LABA) vilanterol (UMEC/VI) are …
[HTML][HTML] Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease …
JF Donohue, D Niewoehner… - Respiratory …, 2014 - respiratory-research.biomedcentral …
The long-acting muscarinic antagonist (LAMA) umeclidinium (UMEC) and the combination
of UMEC with the long-acting β2-agonist (LABA) vilanterol (UMEC/VI) are approved …
of UMEC with the long-acting β2-agonist (LABA) vilanterol (UMEC/VI) are approved …
[HTML][HTML] Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease …
JF Donohue, D Niewoehner, J Brooks… - Respiratory …, 2014 - ncbi.nlm.nih.gov
Background The long-acting muscarinic antagonist (LAMA) umeclidinium (UMEC) and the
combination of UMEC with the long-acting β 2-agonist (LABA) vilanterol (UMEC/VI) are …
combination of UMEC with the long-acting β 2-agonist (LABA) vilanterol (UMEC/VI) are …